Advertisement

Topics

Rubius Therapeutics raises $120m to advance red blood cell technology

05:33 EDT 22 Jun 2017 | Pharmaceutical Business Review

Rubius Therapeutics, which is developing red-cell therapeutics (RCTs) as a new class of medicines to address a range of indications, has raised $120m in a highly oversubscribed private financing.

Original Article: Rubius Therapeutics raises $120m to advance red blood cell technology

NEXT ARTICLE

More From BioPortfolio on "Rubius Therapeutics raises $120m to advance red blood cell technology"

Quick Search
Advertisement